-
Document de presse | 2012.01.22
Launching of the Institut Pasteur in Laos
Today, Monday January 23, 2012, in Vientiane the launch of the Institut Pasteur in Laos was officiated by the Lao Minister of Public Health, professor Som Ock Kingsadat and the President of the Institut Pasteur in Paris, professor Alice Dautry. This is the Institut Pasteur International Network’s 32nd institute. The new research center for infectious and parasitic diseases aims to reduce...
-
Document de presse | 2007.02.21
Aquatic Predator Insect Saliva May Protect Against Buruli Ulcer
Buruli ulcer is a necrotizing skin disease that is very disabling, caused by bacteria that inhabit aquatic environment. It is rife in several regions of the world and is developing at a disturbing rate in West Africa. Researchers at the Institut Pasteur and Inserm, working together with university and institute teams from the Institut Pasteur International Network, recently proved that the...
-
Document de presse | 2005.04.13
The art of camouflaging the parasite responsible for malaria
Researchers from the Institut Pasteur and the CNRS have brought to light the unique mechanisms that allow the parasite responsible for malaria to fool the immune system of those it infects. In collaboration with researchers from the Walter and Eliza Hall Institute of Medical Research of Melbourne, they showed in two articles published in Cell that the parasite is capable of changing the...
-
Document de presse | 2004.09.21
Stem Cells and Skeletar Muscle: a Pagadigme Revised
Two groups at the Institut Pasteur in association with the CNRS (French National Scientific Research Centre) have called into question a 10-year-old paradigm by showing that three genetic factors, and not two as commonly believed, determine skeletal muscle identity from stem cells. This work, published on September 23rd in Nature, changes our view of the determination of muscle cells, and of the...
-
Fiche maladie | 2016.06.21
Zika
The Zika virus is a Flavivirus mainly transmitted by the bite of infected mosquitoes of the genus Aedes. It causes Zika virus disease.
-
Fiche maladie | 2019.10.16
Chikungunya
Chikungunya is a viral disease transmitted to humans by the bite of Aedes albopictus and Aedes aegypti mosquitoes. Although rarely fatal, chikungunya can cause significant pain and debilitating symptoms that affect patients' quality of life. Existing treatments are solely symptomatic. In France, the current conditions in 80% of départements are conducive to the emergence of chikungunya.
-
News | 2016.11.08
The Ebola virus adapted to better infect humans during the 2013-2016 epidemic
An international coalition of scientists* involving teams from the Institut Pasteur, has revealed that adaptive mutations to the Ebola virus occurred during the epidemic that swept across West Africa from 2013 onwards. In what remains the most devastating outbreak of this disease ever recorded, it was already known that several strains of the virus circulated at the same time. This new functional...
-
News | 2016.12.08
Congratulations are in order for the Pasteur iGEM 2016 team!
On Friday December 9 this year, the 19 students* in the Pasteur iGEM 2016 team receive their awards at a ceremony that took place in the Institut Pasteur’s Duclaux lecture hall in Paris. For the second consecutive year the team excelled in the iGEM (international Genetically Engineered Machine) competition, an annual event to promote research in synthetic biology. The team returned from the...
-
Document de presse | 2017.02.27
Infravec2 project launch: A European Commission 10M€ effort to fight mosquito-transmitted diseases
On February 14, the European Commission officially approved the Infravec2 project . This project will improve the European large-scale facilities (infrastructures) for research on mosquitoes and other insects (vectors) that carry human and animal diseases, and will promote sharing of the facilities by European researchers. The Infravec2 project is funded by the Commission’s Horizon 2020...
-
Document de presse | 2017.07.20
Gene therapy: first results in children with Sanfilippo B syndrome
On July 13, 2017, the journal Lancet Neurology published the results of a gene therapy trial conducted in four children with Sanfilippo type B syndrome (also known as MPS IIIB). This trial is the achievement of a two-decade partnership with financial support of AFM-Téléthon and the cooperation of the charity "Vaincre les Maladies Lysosomales" (VML). After monitoring of the treated children for 30...